IRIS
ROSSI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.733
Totale 1.733
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.733
Totale 1.733
Salva come PNG Salva come JPEG
Città #
Genova 575
Genoa 562
Rapallo 323
Vado Ligure 262
Bordighera 11
Totale 1.733
Salva come PNG Salva come JPEG
Nome #
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer 126
New insights on the role of luteinizing hormone releasing hormone agonists in premenopausal early breast cancer patients 121
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study 101
Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer 96
Comparison between 18F-FDG-PET- and CT-based criteria in non-small cell lung cancer (NSCLC) patients treated with Nivolumab 92
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer 91
The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients 82
CIMAvax-EGF, a therapeutic non-small cell lung cancer vaccine 76
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients 73
Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer 73
Vinflunine for the treatment of non-small cell lung cancer 73
Afatinib and Erlotinib in the treatment of squamous-cell lung cancer 68
Radiomic detection of EGFR mutations in NSCLC 68
Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds 67
Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center 63
The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer 60
Exploring Response to Immunotherapy in Non-Small Cell Lung Cancer Using Delta-Radiomics 58
Liquid biopsy in non-small cell lung cancer: Highlights and challenges 56
Radiomic-based diagnostics in oncology: challenges toward clinical practice 54
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience 53
Novel emerging molecular targets in non-small cell lung cancer 51
The role of the immune metabolic prognostic index in patients with non-small cell lung cancer (Nsclc) in radiological progression during treatment with nivolumab 48
Platelets and their derived extracellular vesicles: The new generation of markers in non-small cell lung cancer management 43
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature 42
Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer 32
Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients 31
Prognostic relevance of circulating tumor cells and circulating cell-free DNA association in metastatic non-small cell lung cancer treated with nivolumab 11
Totale 1.809
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.158
article - articoli 9.158
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.316
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202057 0 0 0 0 0 0 0 0 20 21 13 3
2020/2021245 3 4 3 87 47 3 6 25 26 28 5 8
2021/2022217 19 8 6 10 13 18 1 39 25 26 18 34
2022/2023361 21 25 5 38 79 57 4 24 50 10 47 1
2023/2024259 4 18 6 30 22 47 32 25 13 21 7 34
2024/2025556 30 40 19 71 62 80 62 169 23 0 0 0
Totale 1.809